Serotonin and molecular neuroimaging in humans using PET

Amino Acids

Volumn 42, Issue 6, 2012, Pages 2039-2057

  Saulin, Anne ^a   Savli, Markus ^a   Lanzenberger, Rupert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Human brain; In vivo; Molecular imaging; Neuroimaging; PET; Radioligand; Serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ATYPICAL ANTIPSYCHOTIC AGENT; FLUOXETINE; RADIOPHARMACEUTICAL AGENT; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 1E RECEPTOR; SEROTONIN 1F RECEPTOR; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 6 AGONIST; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

ALCOHOL ABUSE; ANXIETY DISORDER; BINDING SITE; DEPRESSION; DRUG ABUSE; FIBROMYALGIA; HUMAN; IRRITABLE COLON; LEARNING; MAJOR DEPRESSION; MEMORY CONSOLIDATION; MENTAL DISEASE; MOLECULAR IMAGING; MOOD; NEUROIMAGING; NONHUMAN; OBESITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; REVIEW; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; SLEEP PATTERN;

ANIMALS; BRAIN; HUMANS; MICE; MOLECULAR IMAGING; MONOAMINE OXIDASE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 84862737660     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-011-1078-9     Document Type: Review

References (203)

1. KH Adams ES Hansen LH Pinborg SG Hasselbalch C Svarer S Holm TG Bolwig GM Knudsen 2005 Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei Int J Neuropsychopharmacol 8 3 391 401 15801987 1:CAS:528:DC%2BD2MXlsFantbg%3D 10.1017/S1461145705005055 S1461145705005055
2. E Akimova R Lanzenberger S Kasper 2009 The serotonin-1A receptor in anxiety disorders Biol Psychiatry 66 7 627 635 19423077 1:CAS:528: DC%2BD1MXhtFWqtLbI 10.1016/j.biopsych.2009.03.012 S0006-3223(09)00392-8
3. JD Andersson ME Pierson SJ Finnema B Gulyas R Heys CS Elmore L Farde C Halldin 2011 Development of a PET radioligand for the central 5-HT1B receptor: radiosynthesis and characterization in cynomolgus monkeys of eight radiolabeled compounds Nucl Med Biol 38 2 261 272 21315282 1:CAS:528:DC%2BC3MXhvFGqur8%3D 10.1016/j.nucmedbio.2010.08.006 S0969-8051(10)00413-0
4. J Andries L Lemoine D Le Bars L Zimmer T Billard 2011 Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers Eur J Med Chem 46 8 3455 3461 21620533 1:CAS:528:DC%2BC3MXnsVeru7k%3D 10.1016/j.ejmech. 2011.05.010 S0223-5234(11)00372-2
5. E Assem-Hilger R Lanzenberger M Savli W Wadsak M Mitterhauser LK Mien E Stogmann C Baumgartner K Kletter S Asenbaum 2010 Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-(11)C]WAY-100635 PET study Epilepsy Behav 19 3 467 473 20850389 10.1016/j.yebeh.2010.07.030 S1525-5050(10)00531-7
6. UF Bailer GK Frank SE Henry JC Price CC Meltzer L Weissfeld CA Mathis WC Drevets A Wagner J Hoge SK Ziolko CW McConaha WH Kaye 2005 Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635 Arch Gen Psychiatry 62 9 1032 1041 16143735 1:CAS:528:DC%2BD2MXhtVGgtrvE 10.1001/archpsyc.62.9.1032
7. AW Bergen MB van den Bree M Yeager R Welch JK Ganjei K Haque S Bacanu WH Berrettini DE Grice D Goldman CM Bulik K Klump M Fichter K Halmi A Kaplan M Strober J Treasure B Woodside WH Kaye 2003 Candidate genes for anorexia nervosa in the 1p33-36 linkage region: serotonin 1D and delta opioid receptor loci exhibit significant association to anorexia nervosa Mol Psychiatry 8 4 397 406 10.1038/sj.mp.40013184001318 12740597 1:CAS:528:DC%2BD3sXjsFOjurs%3D 10.1038/sj.mp.4001318
8. 11C- harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies Nucl Med Biol 24 4 287 293 9257326 10.1016/S0969-8051(97)00013-9 S0969-8051(97)00013-9
9. P Blier B Seletti F Gilbert SN Young C Benkelfat 2002 Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation Neuropsychopharmacology 27 2 301 308 12093604 1:CAS:528:DC%2BD38XkvFyqt7s%3D 10.1016/S0893-133X(02)00318-4 S0893133X02003184
10. J Bockaert H Ansanay S Letty E Marchetti-Gauthier F Roman G Rondouin L Fagni B Soumireu-Mourat A Dumuis 1998 5-HT4 receptors: long-term blockade of K+ channels and effects on olfactory memory C R Acad Sci III 321 2-3 217 221 9759344 1:CAS:528:DyaK1MXmvFSit7c%3D 10.1016/S0764-4469(97)89825-3
11. J Bockaert J Perroy C Becamel P Marin L Fagni 2010 GPCR interacting proteins (GIPs) in the nervous system: roles in physiology and pathologies Annu Rev Pharmacol Toxicol 50 89 109 10.1146/annurev.pharmtox.010909.105705 20055699 1:CAS:528:DC%2BC3cXisVeltbY%3D 10.1146/annurev.pharmtox.010909.105705
12. 11C]DTBZ study in humans Synapse 64 6 417 420 10.1002/syn.20743 20169578 1:CAS:528:DC%2BC3cXkslOis74%3D 10.1002/syn.20743
13. DW Bonhaus C Bach A DeSouza FH Salazar BD Matsuoka P Zuppan HW Chan RM Eglen 1995 The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors Br J Pharmacol 115 4 622 628 7582481 1:CAS:528:DyaK2MXmtlOht7k%3D
14. 11C]befloxatone J Pharmacol Exp Ther 305 2 467 473 10.1124/jpet.102.046953 12606609 1:CAS:528:DC%2BD3sXjt12mtLk%3D 10.1124/jpet.102.046953
15. A Bourson V Kapps C Zwingelstein A Rudler FG Boess AJ Sleight 1997 Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice N S Arch Pharmacol 356 6 820 826 1:CAS:528: DyaK2sXnsFeqtbk%3D 10.1007/PL00005123
16. 11C]DASB imaging of serotonin transporters in patients with alcoholism Alcohol Clin Exp Res 31 1 28 32 17207098 1:CAS:528:DC%2BD2sXhvVOmsbY%3D 10.1111/j.1530-0277.2006.00261.x
17. SM Burke E van de Giessen M de Win T Schilt M van Herk W van den Brink J Booij 2011 Serotonin and dopamine transporters in relation to neuropsychological functioning, personality traits and mood in young adult healthy subjects Psychol Med 41 2 419 429 20367893 1:STN:280:DC%2BC3M%2FoslOqsQ%3D%3D 10.1017/S0033291710000486 S0033291710000486
18. PW Burnet SL Eastwood PJ Harrison 1996 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia Neuropsychopharmacology 15 5 442 455 8914117 1:STN:280:DyaK2s%2FntFWqsA%3D%3D 10.1016/S0893-133X(96)00053-X S0893-133X(96)00053-X
19. DJ Canney MP Kung HF Kung 1995 Amino- and amido-tetrabenazine derivatives: synthesis and evaluation as potential ligands for the vesicular monoamine transporter Nucl Med Biol 22 4 527 535 7550031 1:CAS:528: DyaK2MXntVamsb8%3D 10.1016/0969-8051(94)00118-4
20. 3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord Neuropharmacology 36 4-5 535 542 9225278 1:CAS:528:DyaK2sXktlShsrY%3D 10.1016/S0028-3908(97)00061-0
21. WS Choi BH Lee JC Yang YK Kim 2010 Association study between 5-HT1A receptor gene C(-1019)G polymorphism and panic disorder in a Korean population Psychiatry Investig 7 2 141 146 10.4306/pi.2010.7.2.141 20577624 1:CAS:528:DC%2BC3cXpslans7w%3D 10.4306/pi.2010.7.2.141
22. DC Chugani O Muzik P Chakraborty T Mangner HT Chugani 1998 Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-l- tryptophan Synapse 28 1 33 43 10.1002/(SICI)1098-2396(199801)28:1<33::AID- SYN5>3.0.CO;2-D 9414016 1:CAS:528:DyaK2sXns1Kmtrs%3D 10.1002/(SICI)1098- 2396(199801)28:1<33::AID-SYN5>3.0.CO;2-D
23. T Cigler KS LaForge PF McHugh SU Kapadia SM Leal MJ Kreek 2001 Novel and previously reported single-nucleotide polymorphisms in the human 5-HT(1B) receptor gene: no association with cocaine or alcohol abuse or dependence Am J Med Genet 105 6 489 497 10.1002/ajmg.1473 11496363 1:STN:280: DC%2BD3MvltVSqug%3D%3D 10.1002/ajmg.1473
24. X Codony JM Vela MJ Ramirez 2011 5-HT(6) receptor and cognition Curr Opin Pharmacol 11 1 94 100 21330210 1:CAS:528:DC%2BC3MXks1Wqs7c%3D 10.1016/j.coph.2011.01.004 S1471-4892(11)00005-1
25. V Compan M Zhou R Grailhe RA Gazzara R Martin J Gingrich A Dumuis D Brunner J Bockaert R Hen 2004 Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knock-out mice J Neurosci 24 2 412 419 10.1523/JNEUROSCI.2806-03.200424/2/412 14724239 1:CAS:528: DC%2BD2cXpvVOqtw%3D%3D 10.1523/JNEUROSCI.2806-03.2004
26. VDS Costa-Aze F Dauphin M Boulouard 2011 Serotonin 5-HT6 receptor blockade reverses the age-related deficits of recognition memory and working memory in mice Behav Brain Res 222 1 134 140 10.1016/j.bbr.2011.03.046 10.1016/j.bbr.2011.03.046 1:CAS:528:DC%2BC3MXmtFWqtb8%3D
27. LC Daws GG Gould 2011 Ontogeny and regulation of the serotonin transporter: providing insights into human disorders Pharmacol Ther 131 1 61 79 10.1016/j.pharmthera.2011.03.013 21447358 1:CAS:528:DC%2BC3MXmsVyltbg%3D 10.1016/j.pharmthera.2011.03.013
28. 11C]-labelled pyrrole-2-carboxamide derivates as novel radioligands for PET imaging of monoamine oxidase A Nucl Med Biol 37 4 459 467 20447558 10.1016/j.nucmedbio. 2009.09.005 1:CAS:528:DC%2BC3cXlvVejurc%3D S0969-8051(09)00244-3
29. 18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging Nucl Med Biol 37 4 487 495 10.1016/j.nucmedbio.2010.02.002 20447561 1:CAS:528: DC%2BC3cXlvVeju7w%3D 10.1016/j.nucmedbio.2010.02.002
30. G Demarquay A Lothe JP Royet N Costes G Mick F Mauguiere P Ryvlin 2011 Brainstem changes in 5-HT(1A) receptor availability during migraine attack Cephalalgia 31 1 84 94 10.1177/0333102410385581 21036859 1:STN:280: DC%2BC3M7gtFGisA%3D%3D 10.1177/0333102410385581
31. 18F]MPPF PET study in narcolepsy Neuroimage 30 2 341 348 16275016 10.1016/j.neuroimage.2005.09.052 S1053-8119(05)00758-5
32. A Didelot P Ryvlin A Lothe I Merlet A Hammers F Mauguiere 2008 PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy Brain 131 Pt 10 2751 2764 18790822 10.1093/brain/awn220
33. WC Drevets ME Thase EL Moses-Kolko J Price E Frank DJ Kupfer C Mathis 2007 Serotonin-1A receptor imaging in recurrent depression: replication and literature review Nucl Med Biol 34 7 865 877 17921037 1:CAS:528: DC%2BD2sXhtFeiu7%2FJ 10.1016/j.nucmedbio.2007.06.008
34. K Dunlap GD Fischbach 1981 Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones J Physiol 317 519 535 6118434 1:CAS:528:DyaL3MXlt1KgsL8%3D
35. MS Duxon TP Flanigan AC Reavley GS Baxter TP Blackburn KC Fone 1997 Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system Neuroscience 76 2 323 329 9015317 1:CAS:528:DyaK2sXnt1KhtA%3D%3D 10.1016/S0306-4522(96)00480-0 S0306-4522(96)00480-0
36. JC Ehlen GH Grossman JD Glass 2001 In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus J Neurosci 21 14 5351 5357 21/14/5351 11438611 1:CAS:528:DC%2BD3MXkvFSrsLY%3D
37. MA Enoch WH Kaye A Rotondo BD Greenberg DL Murphy D Goldman 1998 5-HT2A promoter polymorphism -1438G/A, anorexia nervosa, and obsessive-compulsive disorder Lancet 351 9118 1785 1786 9635956 1:CAS:528:DyaK1cXksV2qt7w%3D 10.1016/S0140-6736(05)78746-8 S0140-6736(05)78746-8
38. Enoch MA, Gorodetsky E, Hodgkinson C, Roy A, Goldman D (2010) Functional genetic variants that increase synaptic serotonin and 5-HT3 receptor sensitivity predict alcohol and drug dependence. Mol Psychiatry
39. M Errico RA Crozier MR Plummer DS Cowen 2001 5-HT(7) receptors activate the mitogen activated protein kinase extracellular signal related kinase in cultured rat hippocampal neurons Neuroscience 102 2 361 367 11166122 1:CAS:528:DC%2BD3MXpslyhsQ%3D%3D 10.1016/S0306-4522(00)00460-7 S0306-4522(00)00460-7
40. D Erritzoe H Rasmussen KT Kristiansen VG Frokjaer S Haugbol L Pinborg W Baare C Svarer J Madsen H Lublin GM Knudsen BY Glenthoj 2008 Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients Neuropsychopharmacology 33 10 2435 2441 18288096 1:CAS:528:DC%2BD1cXpslSisb8%3D 10.1038/sj.npp.1301656
41. D Erritzoe VG Frokjaer MT Haahr J Kalbitzer C Svarer KK Holst DL Hansen TL Jernigan S Lehel GM Knudsen 2010 Cerebral serotonin transporter binding is inversely related to body mass index Neuroimage 52 1 284 289 20382236 1:CAS:528:DC%2BC3cXovFSnsro%3D 10.1016/j.neuroimage.2010.03.086 S1053-8119(10)00394-0
42. V Erspamer B Asero 1952 Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine Nature 169 4306 800 801 14941051 1:CAS:528:DyaG3sXhs1Cktw%3D%3D 10.1038/169800b0
43. 11C-phenethylamines as 5-HT (2A) agonist PET tracers Eur J Nucl Med Mol Imaging 38 4 681 693 10.1007/s00259-010-1686-8 21174090 1:CAS:528:DC%2BC3MXivFyksLo%3D 10.1007/s00259-010-1686-8
44. MD Ferrari M Farkkila U Reuter A Pilgrim C Davis M Krauss HC Diener 2010 Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan-a randomised proof-of-concept trial Cephalalgia 30 10 1170 1178 20855362 10.1177/0333102410375512
45. 11C-labeled suicide inactivators and PET Science 235 4787 481 485 3099392 1:CAS:528:DyaL2sXhtlCis7s%3D 10.1126/science.3099392
46. JS Fowler J Logan ND Volkow GJ Wang RR MacGregor YS Ding 2002 Monoamine oxidase: radiotracer development and human studies Methods 27 3 263 277 12183115 1:CAS:528:DC%2BD38XmtFWhsrY%3D 10.1016/S1046-2023(02)00083-X S104620230200083X
47. JS Fowler J Logan ND Volkow GJ Wang 2005 Translational neuroimaging: positron emission tomography studies of monoamine oxidase Mol Imaging Biol 7 6 377 387 10.1007/s11307-005-0016-1 16265597 10.1007/s11307-005-0016-1
48. JS Fowler J Logan GJ Wang ND Volkow F Telang W Zhu D Franceschi C Shea V Garza Y Xu YS Ding D Alexoff D Warner N Netusil P Carter M Jayne P King P Vaska 2005 Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers J Nucl Med 46 9 1414 1420 16157522 1:CAS:528:DC%2BD28XitVGlsbg%3D
49. GK Frank WH Kaye CC Meltzer JC Price P Greer C McConaha K Skovira 2002 Reduced 5-HT2A receptor binding after recovery from anorexia nervosa Biol Psychiatry 52 9 896 906 12399143 1:CAS:528:DC%2BD38XotVWms7s%3D 10.1016/S0006-3223(02)01378-1 S0006322302013781
50. M Fukui RM Rodriguiz J Zhou SX Jiang LE Phillips MG Caron WC Wetsel 2007 Vmat2 heterozygous mutant mice display a depressive-like phenotype J Neurosci 27 39 10520 10529 17898223 1:CAS:528:DC%2BD2sXhtFGmt7fN 10.1523/JNEUROSCI.4388-06. 2007
51. JD Gallezot N Nabulsi A Neumeister B Planeta-Wilson WA Williams T Singhal S Kim RP Maguire T McCarthy JJ Frost Y Huang YS Ding RE Carson 2010 Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans J Cereb Blood Flow Metab 30 1 196 210 19773803 1:CAS:528:DC%2BC3cXos1Sq 10.1038/jcbfm.2009.195
52. RL Gannon JL Peglion MJ Millan 2009 Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram Eur Neuropsychopharmacol 19 12 887 897 19604677 1:CAS:528:DC%2BD1MXhtlCms7zJ 10.1016/j.euroneuro.2009.06.011 S0924-977X(09)00165-5
53. M Gao M Wang GD Hutchins QH Zheng 2008 Synthesis of new carbon-11 labeled benzoxazole derivatives for PET imaging of 5-HT(3) receptor Eur J Med Chem 43 7 1570 1574 18045745 1:CAS:528:DC%2BD1cXnvFyktLg%3D 10.1016/j.ejmech.2007.10.017 S0223-5234(07)00399-6
54. F Gerstl C Windischberger M Mitterhauser W Wadsak A Holik K Kletter E Moser S Kasper R Lanzenberger 2008 Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET Neuroimage 41 2 204 211 18420427 10.1016/j.neuroimage.2008.02.044 S1053-8119(08)00196-1
55. MA Geyer FX Vollenweider 2008 Serotonin research: contributions to understanding psychoses Trends Pharmacol Sci 29 9 445 453 19086254 1:CAS:528:DC%2BD1cXhtVKnurrN 10.1016/j.tips.2008.06.006 S0165-6147(08)00154-5
56. 11C]-harmine binding to monoamine oxidase-A in the human brain J Cereb Blood Flow Metab 26 3 330 344 16079787 1:CAS:528:DC%2BD28XjslCluro%3D 10.1038/sj.jcbfm.9600197
57. DJ Goldstein KI Roon WW Offen NM Ramadan LA Phebus KW Johnson JM Schaus MD Ferrari 2001 Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial Lancet 358 9289 1230 1234 11675061 1:CAS:528:DC%2BD3MXnslWmsrw%3D 10.1016/S0140-6736(01)06347-4 S0140673601063474
58. A Gravius J Laszy M Pietraszek K Saghy J Nagel C Chambon N Wegener B Valastro W Danysz G Istvan 2011 Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity Behav Pharmacol 22 2 122 135 10.1097/FBP. 0b013e328343d804 21301322 1:CAS:528:DC%2BC3MXivVCqs7s%3D 10.1097/FBP. 0b013e328343d804
59. Gunning FM, Smith GS (2011) Functional neuroimaging in geriatric depression. Psychiat Clin North Am 34(2):403. doi: 10.1016/j.psc.2011.02.010
60. MR Guscott E Egan GP Cook JA Stanton MS Beer TW Rosahl S Hartmann J Kulagowski G McAllister KC Fone PH Hutson 2003 The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor Neuropharmacology 44 8 1031 1037 12763096 1:CAS:528:DC%2BD3sXjvFeksLk%3D 10.1016/S0028-3908(03)00117-5 S0028390803001175
61. Halford JCG (2011) The role of serotonin in eating behavior: focus on 5-HT2C receptors 5-HT2C receptors in the pathophysiology of CNS disease. In: Di Giovanni G, Esposito E, Di Matteo V (eds) The receptors, vol 22. Humana Press, USA, pp 339-350. doi: 10.1007/978-1-60761-941-3-17
62. J Hannon D Hoyer 2008 Molecular biology of 5-HT receptors Behav Brain Res 195 1 198 213 18571247 1:CAS:528:DC%2BD1cXhtFOrurbE 10.1016/j.bbr.2008.03.020 S0166-4328(08)00152-6
63. Hasegawa H, Nakamura K (2010) Tryptophan hydroxylase and serotonin synthesis regulation. In: Christian PM, Barry LJ (eds) Handbook of behavioral neuroscience, vol 21. Elsevier, The Netherlands, pp 183-202
64. S Haugbol LH Pinborg L Regeur ES Hansen TG Bolwig FA Nielsen C Svarer LT Skovgaard GM Knudsen 2007 Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome Int J Neuropsychopharmacol 10 2 245 252 16945163 1:CAS:528:DC%2BD2sXhs1Cqs74%3D 10.1017/S1461145706006559 S1461145706006559
65. DJ Heal SL Smith A Fisas X Codony H Buschmann 2008 Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders Pharmacol Ther 117 2 207 231 10.1016/j.pharmthera.2007.08.006 18068807 1:CAS:528:DC%2BD1cXhtV2itrY%3D 10.1016/j.pharmthera.2007.08.006
66. PB Hedlund JG Sutcliffe 2007 The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder Neurosci Lett 414 3 247 251 17267119 1:CAS:528:DC%2BD2sXitl2js78%3D 10.1016/j.neulet.2006.12.054 S0304-3940(06)01332-2
67. S Hesse K Stengler R Regenthal M Patt GA Becker A Franke H Knupfer PM Meyer J Luthardt I Jahn D Lobsien W Heinke P Brust U Hegerl O Sabri 2011 The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder Int J Neuropsychopharmacol 14 5 606 617 21232166 1:CAS:528:DC%2BC3MXlslWmsb4%3D 10.1017/S1461145710001604 S1461145710001604
68. 11C]WAY-100635 Int J Neuropsychopharmacol 11 4 465 476 17971260 1:CAS:528:DC%2BD1cXmt1Kqt74%3D 10.1017/S1461145707008140 S1461145707008140
69. J Holenz PJ Pauwels JL Diaz R Merce X Codony H Buschmann 2006 Medicinal chemistry strategies to 5-HT6 receptor ligands as potential cognitive enhancers and antiobesity agents Drug Discov Today 11 7-8 283 299 16580970 1:CAS:528:DC%2BD28XjtFagtr4%3D 10.1016/j.drudis.2006.02.004
70. C Holmes MJ Arranz JF Powell DA Collier S Lovestone 1998 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease Hum Mol Genet 7 9 1507 1509 9700207 1:CAS:528:DyaK1cXmtVWitbw%3D 10.1093/hmg/7.9.1507
71. 11C]DASB Eur J Nucl Med 27 11 1719 1722 11105830 1:CAS:528:DC%2BD3cXosVWls7s%3D 10.1007/s002590000365
72. J Hu S Henry JD Gallezot J Ropchan JF Neumaier MN Potenza R Sinha JH Krystal Y Huang YS Ding RE Carson A Neumeister 2010 Serotonin 1B receptor imaging in alcohol dependence Biol Psychiatry 67 9 800 803 20172504 1:CAS:528:DC%2BC3cXksFCksrs%3D 10.1016/j.biopsych.2009.12.028 S0006-3223(10)00003-X
73. YY Huang MA Oquendo JM Friedman LL Greenhill B Brodsky KM Malone V Khait JJ Mann 2003 Substance abuse disorder and major depression are associated with the human 5-HT1B receptor gene (HTR1B) G861C polymorphism Neuropsychopharmacology 28 1 163 169 10.1038/sj.npp.1300000 12496953 1:CAS:528:DC%2BD3sXhtlWitr0%3D 10.1038/sj.npp.1300000
74. Y Huang MQ Zheng JM Gerdes 2010 Development of effective PET and SPECT imaging agents for the serotonin transporter: has a twenty-year journey reached its destination? Curr Top Med Chem 10 15 1499 1526 20583995 1:CAS:528: DC%2BC3cXht1ahtr3N
75. 11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys J Neurosci 26 17 4638 4643 16641244 1:CAS:528:DC%2BD28XksFWqurg%3D 10.1523/JNEUROSCI.5199-05.2006
76. JM Jarcho L Chang M Berman B Suyenobu BD Naliboff MD Lieberman VZ Ameen MA Mandelkern EA Mayer 2008 Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study Aliment Pharmacol Ther 28 3 344 352 19086332 1:STN:280: DC%2BD1M%2FjsFWhsg%3D%3D 10.1111/j.1365-2036.2008.03721.x
77. 11C]raclopride Synapse 59 7 427 434 10.1002/syn.20258 16485265 1:CAS:528:DC%2BD28XjvFarsLY%3D 10.1002/syn.20258
78. KW Johnson JM Schaus MM Durkin JE Audia SW Kaldor ME Flaugh N Adham JM Zgombick ML Cohen TA Branchek LA Phebus 1997 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs Neuroreport 8 9-10 2237 2240 9243618 1:CAS:528:DyaK2sXlt1Wgsbk%3D 10.1097/00001756-199707070-00029
79. J Kalbitzer VG Frokjaer D Erritzoe C Svarer P Cumming FA Nielsen SH Hashemi WF Baare J Madsen SG Hasselbalch ML Kringelbach EL Mortensen GM Knudsen 2009 The personality trait openness is related to cerebral 5-HTT levels Neuroimage 45 2 280 285 19135154 10.1016/j.neuroimage.2008.12.001 S1053-8119(08)01267-6
80. S Kasper J Sacher N Klein N Mossaheb T Attarbaschi-Steiner R Lanzenberger C Spindelegger S Asenbaum A Holik R Dudczak 2009 Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram Int Clin Psychopharmacol 24 3 119 125 10.1097/YIC.0b013e32832a8ec8 19367152 10.1097/YIC.0b013e32832a8ec8
81. GA Kennett CT Dourish G Curzon 1987 Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression Eur J Pharmacol 134 3 265 274 2883013 1:CAS:528:DyaL2sXhvVyqs70%3D 10.1016/0014-2999(87)90357-8
82. SJ Kish J Tong O Hornykiewicz A Rajput LJ Chang M Guttman Y Furukawa 2008 Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease Brain 131 Pt 1 120 131 17956909
83. T Kishi Y Fukuo R Yoshimura T Okochi T Kitajima H Naitoh W Umene-Nakano J Nakamura N Ozaki N Iwata 2010 Pharmacogenetic study of serotonin 6 receptor gene with antidepressant response in major depressive disorder in the Japanese population Hum Psychopharmacol 25 6 481 486 10.1002/hup.1142 20737521 1:CAS:528:DC%2BC3cXhtFKrtb7E 10.1002/hup.1142
84. 11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter J Cereb Blood Flow Metab 16 6 1288 1299 10.1097/00004647-199611000-00025 8898703 1:CAS:528:DyaK28XmvVCjt74%3D 10.1097/00004647-199611000-00025
85. 11C]SB207145 in the Gottingen minipig J Cereb Blood Flow Metab 29 1 186 196 18797470 1:CAS:528:DC%2BD1MXht1anuw%3D%3D 10.1038/jcbfm.2008.110
86. GS Kranz S Kasper R Lanzenberger 2010 Reward and the serotonergic system Neuroscience 166 4 1023 1035 20109531 1:CAS:528:DC%2BC3cXivFGhtbo%3D 10.1016/j.neuroscience.2010.01.036 S0306-4522(10)00084-9
87. 11C]DASB PET study Neuroimage 54 2 1336 1343 20851771 10.1016/j.neuroimage.2010.09.010 S1053-8119(10)01191-2
88. RR Lanzenberger M Mitterhauser C Spindelegger W Wadsak N Klein LK Mien A Holik T Attarbaschi N Mossaheb J Sacher T Geiss-Granadia K Kletter S Kasper J Tauscher 2007 Reduced serotonin-1A receptor binding in social anxiety disorder Biol Psychiatry 61 9 1081 1089 16979141 1:CAS:528:DC%2BD2sXkt1ejsbw%3D 10.1016/j.biopsych.2006.05.022 S0006-3223(06)00702-5
89. R Lanzenberger W Wadsak C Spindelegger M Mitterhauser E Akimova LK Mien M Fink U Moser M Savli GS Kranz A Hahn K Kletter S Kasper 2010 Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions Int J Neuropsychopharmacol 13 9 1129 1143 20519060 1:CAS:528:DC%2BC3cXhtFCkurvO 10.1017/S1461145710000581 S1461145710000581
90. M Leopoldo E Lacivita F Berardi R Perrone PB Hedlund 2011 Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders Pharmacol Ther 129 2 120 148 20923682 1:CAS:528:DC%2BC3MXpvVantQ%3D%3D 10.1016/j.pharmthera.2010.08.013 S0163-7258(10)00187-7
91. 11C]befloxatone J Clin Psychopharmacol 29 1 86 88 10.1097/JCP.0b013e31819e98f 19142115 1:CAS:528:DC%2BD1MXkvVShsg%3D%3D 10.1097/JCP.0b013e31819e98f
92. KP Lesch J Gross E Franzek BL Wolozin P Riederer DL Murphy 1995 Primary structure of the serotonin transporter in unipolar depression and bipolar disorder Biol Psychiatry 37 4 215 223 7711157 1:CAS:528:DyaK2MXkvVSltb0%3D 10.1016/0006-3223(94)00147-U
93. 11C]methyl-l-tryptophan trapping in impulsive subjects with borderline personality disorder Am J Psychiatry 158 5 775 782 11329401 1:STN:280:DC%2BD3M3ovVGmtg%3D%3D 10.1176/appi.ajp.158.5.775
94. ME Liechti MR Saur A Gamma D Hell FX Vollenweider 2000 Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans Neuropsychopharmacology 23 4 396 404 10989266 1:CAS:528:DC%2BD3cXmtlGlsL8%3D 10.1016/S0893-133X(00)00126-3 S0893-133X(00)00126-3
95. F Liu VJ Majo J Prabhakaran MS Milak J John Mann RV Parsey JS Dileep Kumar 2011 Synthesis and in vivo evaluation of [O-methyl-(11)C] N-[3, 5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesul fonamide as an imaging probe for 5-HT(6) receptors Bioorg Med Chem 19 17 5255 5259 21821420 1:CAS:528:DC%2BC3MXhtVKlsLzL 10.1016/j.bmc.2011.06.090 S0968-0896(11)00547-5
96. MG Livingston HM Livingston 1996 Monoamine oxidase inhibitors. An update on drug interactions Drug Saf 14 4 219 227 8713690 1:CAS:528:DyaK28Xis1Slsb8%3D 10.2165/00002018-199614040-00002
97. 11C]clorgyline J Cereb Blood Flow Metab 22 11 1367 1376 10.1097/00004647-200211000-00010 12439294 1:CAS:528:DC%2BD38Xosl2gt7g%3D 10.1097/00004647-200211000-00010
98. TW Lovenberg BM Baron L de Lecea JD Miller RA Prosser MA Rea PE Foye M Racke AL Slone BW Siegel, et al. 1993 A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms Neuron 11 3 449 458 8398139 1:CAS:528:DyaK2cXitlKksLo%3D 10.1016/0896-6273(93)90149-L
99. Lucas G, Du J, Romeas T, Mnie-Filali O, Haddjeri N, Pineyro G, Debonnel G (2010) Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat. PLoS ONE 5(2):e9253. doi: 10.1371/journal.pone.0009253
100. TK Machu 2011 Therapeutics of 5-HT3 receptor antagonists: current uses and future directions Pharmacol Ther 130 3 338 347 21356241 1:CAS:528: DC%2BC3MXlsV2nu7k%3D 10.1016/j.pharmthera.2011.02.003 S0163-7258(11)00051-9
101. K Madsen D Erritzoe EL Mortensen A Gade J Madsen W Baare GM Knudsen SG Hasselbalch 2011 Cognitive function is related to fronto-striatal serotonin transporter levels-a brain PET study in young healthy subjects Psychopharmacology (Berl) 213 2-3 573 581 10.1007/s00213-010-1926-4 1:CAS:528:DC%2BC3cXos1Smt70%3D 10.1007/s00213-010-1926-4
102. Madsen K, Neumann WJ, Holst K, Marner L, Haahr MT, Lehel S, Knudsen GM, Hasselbalch SG (2011b) Cerebral serotonin 4 receptors and amyloid-beta in early Alzheimer's disease. J Alzheimers Dis 23
103. R Mahesh T Devadoss DK Pandey S Bhatt SK Yadav 2010 Design, synthesis and structure-activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression Bioorganic Med Chem Lett 20 22 6773 6776 1:CAS:528:DC%2BC3cXhtlSmsLrM 10.1016/j.bmcl.2010.08.128 S0960-894X(10)01264-3
104. 11C]SB207145-PET Neuroimage 50 3 855 861 20096787 1:CAS:528:DC%2BC3cXkslSqtrY%3D 10.1016/j.neuroimage.2010.01.054 S1053-8119(10)00076-5
105. CA Marsden MV King KC Fone 2011 Influence of social isolation in the rat on serotonergic function and memory-relevance to models of schizophrenia and the role of 5-HT6 receptors Neuropharmacology 61 3 400 407 21414329 1:CAS:528:DC%2BC3MXntFWiur4%3D 10.1016/j.neuropharm.2011.03.003 S0028-3908(11)00112-2
106. Martarello L, Ahmed M, Chuang AT, Cunningham VJ, Jakobsen S, Johnson CN, Matthews JC, Medhurst A, Moss SF, Rabiner EA, Ray A, Rivers D, Stemp G, Gee AD (2005) Radiolabelling and in vivo evaluation of [(11)C]Gsk215083 as a potential 5-Ht(6) Pet radioligand in the porcine brain. J Cereb Blood Flow Metab 25:S598
107. FJ Martin-Cora A Pazos 2004 Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species Br J Pharmacol 141 1 92 104 10.1038/sj.bjp.0705576sj.bjp. 0705576 14656806 1:CAS:528:DC%2BD2cXhsFalurY%3D 10.1038/sj.bjp.0705576
108. TF Massoud SS Gambhir 2003 Molecular imaging in living subjects: seeing fundamental biological processes in a new light Genes Dev 17 5 545 580 10.1101/gad.1047403 12629038 1:CAS:528:DC%2BD3sXisVejurY%3D 10.1101/gad.1047403
109. 11C]DASB Neuropsychopharmacology 30 9 1741 1750 15841106 1:CAS:528:DC%2BD2MXotFegu74%3D 10.1038/sj.npp.1300736
110. HY Meltzer 1999 The role of serotonin in antipsychotic drug action Neuropsychopharmacology 21 2 Suppl 106S 115S 10.1016/S0893-133X(99)00046-9 10432496 1:CAS:528:DyaK1MXltVOntb8%3D
111. A Meneses 2007 Stimulation of 5-HT1A, 5-HT1B, 5-HT2A/2C, 5-HT3 and 5-HT4 receptors or 5-HT uptake inhibition: short- and long-term memory Behav Brain Res 184 1 81 90 17692935 1:CAS:528:DC%2BD2sXhtVOgtrnN 10.1016/j.bbr.2007.06.026 S0166-4328(07)00327-0
112. A Meneses G Perez-Garcia 2007 5-HT(1A) receptors and memory Neurosci Biobehav Rev 31 5 705 727 17418894 1:CAS:528:DC%2BD2sXkvFOmtb4%3D 10.1016/j.neubiorev.2007.02.001 S0149-7634(07)00018-8
113. A Meneses G Perez-Garcia G Liy-Salmeron D Flores-Galvez C Castillo E Castillo 2008 The effects of the 5-HT6 receptor agonist EMD and the 5-HT7 receptor agonist AS19 on memory formation Behav Brain Res 195 1 112 119 10.1016/j.bbr.2007.11.023 18191236 1:CAS:528:DC%2BD1cXhtFOrurjP 10.1016/j.bbr.2007.11.023
114. C Messa C Colombo RM Moresco C Gobbo L Galli G Lucignani MC Gilardi G Rizzo E Smeraldi R Zanardi F Artigas F Fazio 2003 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study Psychopharmacology (Berl) 167 1 72 78 10.1007/s00213-002-1379-5 1:CAS:528:DC%2BD3sXislyqsb0%3D
115. JH Meyer 2007 Imaging the serotonin transporter during major depressive disorder and antidepressant treatment J Psychiatry Neurosci 32 2 86 102 17353938
116. JH Meyer N Ginovart A Boovariwala S Sagrati D Hussey A Garcia T Young N Praschak-Rieder AA Wilson S Houle 2006 Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression Arch Gen Psychiatry 63 11 1209 1216 17088501 1:CAS:528:DC%2BD28XhtlSksL%2FJ 10.1001/archpsyc.63.11.1209
117. 11C-CUMI-101, an agonist radiotracer for imaging serotonin 1A receptor in vivo with PET J Nucl Med 49 4 587 596 18344443 1:CAS:528:DC%2BD1cXltl2gtLk%3D 10.2967/jnumed.107.046540
118. 11C-CUMI-101, an agonist PET radiotracer J Nucl Med 51 12 1892 1900 21098796 10.2967/jnumed.110.076257
119. 11C]CUMI-101: a serotonin 1A receptor agonist positron emission tomography radiotracer J Cereb Blood Flow Metab 31 1 243 249 20571518 1:CAS:528:DC%2BC3MXhtleqsg%3D%3D 10.1038/jcbfm.2010.83
120. JM Miller KG Brennan TR Ogden MA Oquendo GM Sullivan JJ Mann RV Parsey 2009 Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality Neuropsychopharmacology 34 10 2275 2284 19458612 1:CAS:528:DC%2BD1MXpvFygtr4%3D 10.1038/npp.2009.54
121. O Mnie-Filali C Faure L Lambas-Senas M El Mansari H Belblidia E Gondard A Etievant H Scarna A Didier A Berod P Blier N Haddjeri 2011 Pharmacological blockade of 5-HT(7) receptors as a putative fast acting antidepressant strategy Neuropsychopharmacology 36 6 1275 1288 21326194 1:CAS:528:DC%2BC3MXks1Wlt7o%3D 10.1038/npp.2011.13
122. JM Monti M Leopoldo H Jantos 2008 The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat Behav Brain Res 191 2 184 189 10.1016/j.bbr.2008.03.025 18466985 1:CAS:528:DC%2BD1cXmtlSgsbo%3D 10.1016/j.bbr.2008.03.025
123. JW Murrough S Henry J Hu JD Gallezot B Planeta-Wilson JF Neumaier A Neumeister 2011 Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder Psychopharmacology (Berl) 213 2-3 547 553 10.1007/s00213-010-1881-0 1:CAS:528:DC%2BC3cXmtFOltbo%3D 10.1007/s00213-010-1881-0
124. 11C]P943 Nucl Med Biol 37 2 205 214 20152720 1:CAS:528:DC%2BC3cXhs1ygtLg%3D 10.1016/j.nucmedbio.2009.10.007 S0969-8051(09)00255-8
125. 11C]fallypride Synapse 63 6 447 461 10.1002/syn.20628 19217025 1:CAS:528:DC%2BD1MXlt1KqsLk%3D 10.1002/syn.20628
126. JR Nash PA Sargent EA Rabiner SD Hood SV Argyropoulos JP Potokar PM Grasby DJ Nutt 2008 Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study Br J Psychiatry 193 3 229 234 18757983 10.1192/bjp.bp.107.041186
127. L Neeb J Meents U Reuter 2010 5-HT(1F) Receptor agonists: a new treatment option for migraine attacks? Neurotherapeutics 7 2 176 182 10.1016/j.nurt.2010. 03.003 20430316 1:CAS:528:DC%2BC3cXntlOnur0%3D 10.1016/j.nurt.2010.03.003
128. JF Neumaier ES Vincow A Arvanitogiannis RA Wise WA Carlezon Jr 2002 Elevated expression of 5-HT1B receptors in nucleus accumbens efferents sensitizes animals to cocaine J Neurosci 22 24 10856 10863 12486179 1:CAS:528:DC%2BD38XpslCqt7k%3D
129. A Neumeister E Bain AC Nugent RE Carson O Bonne DA Luckenbaugh W Eckelman P Herscovitch DS Charney WC Drevets 2004 Reduced serotonin type 1A receptor binding in panic disorder J Neurosci 24 3 589 591 10.1523/JNEUROSCI.4921-03.2004 14736842 1:CAS:528:DC%2BD2cXht1Cjtbw%3D 10.1523/JNEUROSCI.4921-03.2004
130. Nikiforuk A, Kos T, Wesolowska A (2011) The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. Psychopharmacology (Berl). doi: 10.1007/s00213-011-2297-1
131. M Nishikawa Y Kumakura SN Young P Fiset N Vogelzangs M Leyton C Benkelfat M Diksic 2005 Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using alpha-[(11)C]methyl-l-tryptophan and positron emission tomography Neurochem Int 47 8 556 564 16157418 1:CAS:528: DC%2BD2MXhtFSis7vP 10.1016/j.neuint.2005.07.006 S0197-0186(05)00194-4
132. T Nishikawa NH Tsuno Y Shuno K Sasaki K Hongo Y Okaji E Sunami J Kitayama K Takahashi H Nagawa 2010 Antiangiogenic effect of a selective 5-HT4 receptor agonist J Surg Res 159 2 696 704 19515383 1:CAS:528:DC%2BC3cXjslSmur8%3D 10.1016/j.jss.2008.11.004 S0022-4804(08)00689-6
133. S Nishizawa C Benkelfat SN Young M Leyton S Mzengeza C de Montigny P Blier M Diksic 1997 Differences between males and females in rates of serotonin synthesis in human brain Proc Natl Acad Sci USA 94 10 5308 5313 9144233 1:CAS:528:DyaK2sXjtlelt7Y%3D 10.1073/pnas.94.10.5308
134. Y Ohno 2011 Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease CNS Neurosci Ther 17 1 58 65 10.1111/j.1755-5949.2010.00211.x 21091640 1:CAS:528:DC%2BC3MXisVCnurc%3D 10.1111/j.1755-5949.2010.00211.x
135. N Okamura VL Villemagne J Drago S Pejoska RK Dhamija RS Mulligan JR Ellis U Ackermann G O'Keefe G Jones HF Kung MJ Pontecorvo D Skovronsky CC Rowe 2010 In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133 J Nucl Med 51 2 223 228 20080893 10.2967/jnumed.109.070094
136. 11C]methyl-l-tryptophan J Psychiatry Neurosci 25 4 359 370 11022401 1:STN:280:DC%2BD3cvmvVGrsA%3D%3D
137. B Olivier R van Oorschot 2005 5-HT1B receptors and aggression: a review Eur J Pharmacol 526 1-3 207 217 16310769 1:CAS:528:DC%2BD2MXht1OltbjJ 10.1016/j.ejphar.2005.09.066 S0014-2999(05)00980-5
138. GN Pandey Y Dwivedi X Ren HS Rizavi G Faludi A Sarosi M Palkovits 2006 Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide Neurochem Res 31 2 167 176 10.1007/s11064-005-9006-6 16673176 1:CAS:528:DC%2BD28XktFSrtbs%3D 10.1007/s11064-005-9006-6
139. Parker CA, Cunningham VJ, Martarello L, Rabinera EA, Searle GE, Gee AD, Davy M, Johnson CN, Ahmed M, Gunn RN, Laruelle M (2008) Evaluation of the novel 5-HT6 receptor radioligand, [C-11]GSK-215083 in human. Neuroimage 41:T20-T20. doi: 10.1016/j.neuroimage.2008.04.194
140. RV Parsey RT Ogden JM Miller A Tin N Hesselgrave E Goldstein A Mikhno M Milak F Zanderigo GM Sullivan MA Oquendo JJ Mann 2010 Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations Biol Psychiatry 68 2 170 178 20497898 1:CAS:528: DC%2BC3cXosVGku7k%3D 10.1016/j.biopsych.2010.03.023
141. LM Paterson RJ Tyacke DJ Nutt GM Knudsen 2010 Measuring endogenous 5-HT release by emission tomography: promises and pitfalls J Cereb Blood Flow Metab 30 10 1682 1706 20664611 1:CAS:528:DC%2BC3cXht1els7fF 10.1038/jcbfm.2010.104
142. Paterson LM, Kornum BR, Nutt DJ, Pike VW, Knudsen GM (2011) 5-HT radioligands for human brain imaging with PET and SPECT. Med Res Rev. doi: 10.1002/med.20245
143. A Pazos A Probst JM Palacios 1987 Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors Neuroscience 21 1 97 122 2955249 1:CAS:528:DyaL2sXktlektb8%3D 10.1016/0306-4522(87)90326-5
144. A Pazos A Probst JM Palacios 1987 Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors Neuroscience 21 1 123 139 3601071 1:CAS:528:DyaL2sXktlektbw%3D 10.1016/0306-4522(87)90327-7
145. LA Phebus KW Johnson JM Zgombick PJ Gilbert K Van Belle V Mancuso DL Nelson DO Calligaro AD Kiefer Jr TA Branchek ME Flaugh 1997 Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine Life Sci 61 21 2117 2126 9395253 1:CAS:528:DyaK2sXntVKrtLc%3D 10.1016/S0024-3205(97)00885-0 S0024320597008850
146. D Popa C Lena V Fabre C Prenat J Gingrich P Escourrou M Hamon J Adrien 2005 Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors J Neurosci 25 49 11231 11238 16339018 1:CAS:528:DC%2BD2MXhtlaksr3M 10.1523/JNEUROSCI.1724-05.2005
147. B Pouzet M Didriksen J Arnt 2002 Effects of the 5-HT6 receptor antagonist, SB-271046, in animal models for schizophrenia Pharmacol Biochem Be 71 4 635 643 1:CAS:528:DC%2BD38XhvVChur4%3D 10.1016/S0091-3057(01)00743-2
148. JF Quist CL Barr R Schachar W Roberts M Malone R Tannock VS Basile J Beitchman JL Kennedy 2003 The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder Mol Psychiatry 8 1 98 102 10.1038/sj.mp.4001244 12556913 1:CAS:528:DC%2BD3sXntl2lsQ%3D%3D 10.1038/sj.mp.4001244
149. M Reimold A Knobel MA Rapp A Batra K Wiedemann A Strohle A Zimmer P Schonknecht MN Smolka DR Weinberger D Goldman HJ Machulla R Bares A Heinz 2011 Central serotonin transporter levels are associated with stress hormone response and anxiety Psychopharmacology (Berl) 213 2-3 563 572 10.1007/s00213-010-1903-y 1:CAS:528:DC%2BC3cXotVamt7k%3D 10.1007/s00213-010-1903-y
150. Roberts AJ, Hedlund PB (2011) The 5-HT(7) receptor in learning and memory. Hippocampus. doi: 10.1002/hipo.20938
151. ZA Rodd RL Bell SM Oster JE Toalston TJ Pommer WJ McBride JM Murphy 2010 Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol self-administration of alcohol-preferring (P) rats Alcohol 44 3 245 255 20682192 1:CAS:528:DC%2BC3cXntVagsrg%3D 10.1016/j.alcohol.2010.01.002 S0741-8329(10)00034-0
152. 11C]methyl-l-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression Arch Gen Psychiatry 61 6 556 563 10.1001/archpsyc.61.6.556 15184235 1:CAS:528:DC%2BD2cXlsFCju7c%3D 10.1001/archpsyc.61.6.556
153. 11C]methyl-l-tryptophan brain trapping in healthy male volunteers Eur J Nucl Med Mol Imaging 32 10 1199 1204 10.1007/s00259-005-1829-5 15948006 10.1007/s00259-005-1829-5
154. BM Ruf Z Bhagwagar 2009 The 5-HT1B receptor: a novel target for the pathophysiology of depression Curr Drug Targets 10 11 1118 1138 19702551 1:CAS:528:DC%2BD1MXhsFGqtr%2FF 10.2174/138945009789735192
155. O Russo M Cachard-Chastel C Riviere M Giner JL Soulier M Berthouze T Richard JP Monti S Sicsic F Lezoualc'h I Berque-Bestel 2009 Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease J Med Chem 52 8 2214 2225 10.1021/jm801327q 19334715 1:CAS:528: DC%2BD1MXjvFKlt74%3D 10.1021/jm801327q
156. L Salomon C Lanteri G Godeheu G Blanc J Gingrich JP Tassin 2007 Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors Psychopharmacology (Berl) 194 1 11 20 10.1007/s00213-007-0810- 3 1:CAS:528:DC%2BD2sXptFehu7g%3D 10.1007/s00213-007-0810-3
157. L Santhosh KM Estok RS Vogel GD Tamagnan RM Baldwin EM Mitsis MG Macavoy JK Staley CH van Dyck 2009 Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET Psychiatry Res 173 3 212 217 19682865 1:CAS:528:DC%2BD1MXhtVKlsr7P 10.1016/j.pscychresns.2009.03.007 S0925-4927(09)00083-3
158. F Saudou DA Amara A Dierich M Lemeur S Ramboz L Segu MC Buhot R Hen 1994 Enhanced aggressive-behavior in mice lacking 5-Ht1b receptor Science 265 5180 1875 1878 8091214 1:CAS:528:DyaK2cXlvFKlt7Y%3D 10.1126/science.8091214
159. K Schwartz A Weizman M Rehavi 2005 Decreased platelet vesicular monoamine transporter density in habitual smokers Eur Neuropsychopharmacol 15 2 235 238 15695071 1:CAS:528:DC%2BD2MXhtVOqtLk%3D 10.1016/j.euroneuro.2004.11.001 S0924-977X(04)00193-2
160. Segu L, Lecomte MJ, Wolff M, Santamaria J, Hen R, Dumuis A, Berrard S, Bockaert J, Buhot MC, Compan V (2010) Hyperfunction of muscarinic receptor maintains long-term memory in 5-HT4 receptor knock-out mice. PLoS ONE 5 (3):e9529. doi: 10.1371/journal.pone.0009529
161. MF Seidel W Müller 2011 Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists Expert Opin Pharmacother 12 9 1381 1391 10.1517/14656566.2011.557362 21323622 1:CAS:528:DC%2BC3MXmtFaktLs%3D 10.1517/14656566.2011.557362
162. S Selvaraj R Hoshi Z Bhagwagar NV Murthy R Hinz P Cowen HV Curran P Grasby 2009 Brain serotonin transporter binding in former users of MDMA ('ecstasy') Br J Psychiatry 194 4 355 359 19336788 10.1192/bjp.bp.108.050344
163. A Serretti P Artioli D De Ronchi 2004 The 5-HT2C receptor as a target for mood disorders Expert Opin Ther Targets 8 1 15 23 10.1517/14728222.8.1.15 14996615 1:CAS:528:DC%2BD2cXmvVKhsg%3D%3D 10.1517/14728222.8.1.15
164. J Shelton P Bonaventure X Li S Yun T Lovenberg C Dugovic 2009 5-HT7 receptor deletion enhances REM sleep suppression induced by selective serotonin reuptake inhibitors, but not by direct stimulation of 5-HT1A receptor Neuropharmacology 56 2 448 454 18948124 1:CAS:528:DC%2BD1MXhtVGjurc%3D 10.1016/j.neuropharm.2008.09.014 S0028-3908(08)00457-7
165. JC Shih MJ Ridd K Chen WP Meehan MP Kung I Seif E De Maeyer 1999 Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A Brain Res 835 2 104 112 10415365 1:CAS:528:DyaK1MXktlyitLc%3D 10.1016/S0006-8993(99)01478-X S0006-8993(99)01478-X
166. 18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers Biol Psychiatry 63 12 1135 1140 18191817 1:CAS:528:DC%2BD1cXmsFOjtLs%3D 10.1016/j.biopsych.2007.11.016 S0006-3223(07)01160-2
167. HB Simpson I Lombardo M Slifstein HY Huang DR Hwang A Abi-Dargham MR Liebowitz M Laruelle 2003 Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652 Biol Psychiatry 54 12 1414 1421 14675806 1:CAS:528:DC%2BD3sXpvVWqt7Y%3D 10.1016/S0006-3223(03)00544-4 S0006322303005444
168. A Soliman RM Bagby AA Wilson L Miler M Clark P Rusjan J Sacher S Houle JH Meyer 2011 Relationship of monoamine oxidase A binding to adaptive and maladaptive personality traits Psychol Med 41 5 1051 1060 20810002 1:STN:280:DC%2BC3MzivFyjsw%3D%3D 10.1017/S0033291710001601 S0033291710001601
169. M Soyka UW Preuss G Koller P Zill B Bondy 2004 Association of 5-HT1B receptor gene and antisocial behavior in alcoholism J Neural Transm 111 1 101 109 10.1007/s00702-003-0064-0 14714219 1:CAS:528:DC%2BD2cXhtlGkug%3D%3D 10.1007/s00702-003-0064-0
170. C Spindelegger R Lanzenberger W Wadsak LK Mien P Stein M Mitterhauser U Moser A Holik L Pezawas K Kletter S Kasper 2009 Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders Mol Psychiatry 14 11 1040 1050 18362913 1:CAS:528:DC%2BD1MXhtlSgs7jM 10.1038/mp.2008.35
171. N Suzuki N Hajicek T Kozasa 2009 Regulation and physiological functions of G12/13-mediated signaling pathways Neurosignals 17 1 55 70 10.1159/000186690 19212140 1:CAS:528:DC%2BD1MXhslyit7o%3D 10.1159/000186690
172. TN Taylor WM Caudle KR Shepherd A Noorian CR Jackson PM Iuvone D Weinshenker JG Greene GW Miller 2009 Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity J Neurosci 29 25 8103 8113 19553450 1:CAS:528:DC%2BD1MXotFKgtbs%3D 10.1523/JNEUROSCI.1495- 09.2009
173. LH Tecott LM Sun SF Akana AM Strack DH Lowenstein MF Dallman D Julius 1995 Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors Nature 374 6522 542 546 10.1038/374542a0 7700379 1:CAS:528:DyaK2MXkvVKqtr4%3D 10.1038/374542a0
174. DR Thomas 2006 5-ht5A receptors as a therapeutic target Pharmacol Ther 111 3 707 714 16516972 1:CAS:528:DC%2BD28Xns1Sks7o%3D 10.1016/j.pharmthera.2005. 12.006 S0163-7258(06)00003-9
175. DR Thomas EM Soffin C Roberts JN Kew RM de la Flor LA Dawson VA Fry SA Coggon S Faedo PD Hayes DF Corbett CH Davies JJ Hagan 2006 SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]me thyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain Neuropharmacology 51 3 566 577 16846620 1:CAS:528:DC%2BD28XotlOjt7k%3D 10.1016/j.neuropharm.2006. 04.019 S0028-3908(06)00121-3
176. A Tillinger A Sollas LI Serova R Kvetnansky EL Sabban 2010 Vesicular monoamine transporters (VMATs) in adrenal chromaffin cells: stress-triggered induction of VMAT2 and expression in epinephrine synthesizing cells Cell Mol Neurobiol 30 8 1459 1465 10.1007/s10571-010-9575-z 21046458 1:CAS:528: DC%2BC3cXhs1Wns7zE 10.1007/s10571-010-9575-z
177. Tong J, Boileau I, Furukawa Y, Chang LJ, Wilson AA, Houle S, Kish SJ (2011) Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies. J Cereb Blood Flow Metab
178. SJ Tsai HC Liu TY Liu YC Wang CJ Hong 1999 Association analysis of the 5-HT6 receptor polymorphism C267T in Alzheimer's disease Neurosci Lett 276 2 138 139 10624811 1:CAS:528:DyaK1MXntlemu7Y%3D 10.1016/S0304-3940(99)00802-2 S0304-3940(99)00802-2
179. CW Tsao YS Lin CC Chen CH Bai SR Wu 2006 Cytokines and serotonin transporter in patients with major depression Prog Neuropsychopharmacol Biol Psychiatry 30 5 899 905 16616982 1:CAS:528:DC%2BD28XltlemsbY%3D 10.1016/j.pnpbp.2006.01.029 S0278-5846(06)00056-X
180. BM Twarog IH Page 1953 Serotonin content of some mammalian tissues and urine and a method for its determination Am J Physiol 175 1 157 161 13114371 1:CAS:528:DyaG2cXns1yl
181. TM Vander Borght MR Kilbourn RA Koeppe JN DaSilva DE Kuhl KA Frey 1995 In vivo imaging of the brain vesicular monoamine transporter J Nucl Med 36 12 2252 2260 8523116 1:CAS:528:DyaK28XhtVSlt7Y%3D
182. 11C]AZ10419369 binding to 5-HT1B receptors in human brain J Cereb Blood Flow Metab 31 1 113 123 20424633 10.1038/jcbfm.2010.55 1:CAS:528:DC%2BC3MXhtlCjsw%3D%3D
183. 11C]AZ10419369 Psychopharmacology (Berl) 213 2-3 533 545 10.1007/s00213-011-2165-z 10.1007/s00213-011-2165-z 1:CAS:528:DC%2BC3MXmsFCktA%3D%3D
184. VL Villemagne N Okamura S Pejoska J Drago RS Mulligan G Chetelat U Ackermann G O'Keefe G Jones S Gong H Tochon-Danguy HF Kung CL Masters DM Skovronsky CC Rowe 2011 In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease Arch Neurol 68 7 905 912 21747030 10.1001/archneurol.2011.142
185. AK Visser A van Waarde AT Willemsen FJ Bosker PG Luiten JA den Boer IP Kema RA Dierckx 2011 Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications Eur J Nucl Med Mol Imaging 38 3 576 591 10.1007/s00259-010-1663-2 21113591 1:CAS:528:DC%2BC3MXhs1Gjs7s%3D 10.1007/s00259-010-1663-2
186. IR Vogt D Shimron-Abarbanell H Neidt J Erdmann S Cichon TG Schulze DJ Muller W Maier M Albus M Borrmann-Hassenbach M Knapp M Rietschel P Propping MM Nothen 2000 Investigation of the human serotonin 6 [5-HT6] receptor gene in bipolar affective disorder and schizophrenia Am J Med Genet 96 2 217 221 10.1002/(SICI)1096-8628(20000403)96:2<217::AID-AJMG17>3.0.CO;2-0 10893499 1:STN:280:DC%2BD3cvitlymsw%3D%3D 10.1002/(SICI)1096-8628(20000403)96:2<217:: AID-AJMG17>3.0.CO;2-0
187. B Volk BJ Nagy S Vas D Kostyalik G Simig G Bagdy 2010 Medicinal chemistry of 5-HT5A receptor ligands: a receptor subtype with unique therapeutical potential Curr Top Med Chem 10 5 554 578 20166946 1:CAS:528:DC%2BC3cXlsFKnur4%3D 10.2174/156802610791111588
188. 18F]AV-133 radiotracers in a rat model of Parkinson's disease Nucl Med Biol 37 4 479 486 20447560 1:CAS:528:DC%2BC3cXlvVeju78%3D 10.1016/j.nucmedbio.2010.01.006 S0969-8051(10)00028-4
189. 18F]AV-133 radiotracers in a rat model of Parkinson's disease Nucl Med Biol 37 4 479 486 20447560 1:CAS:528:DC%2BC3cXlvVeju78%3D 10.1016/j.nucmedbio.2010.01.006 S0969-8051(10)00028-4
190. A Wesolowska 2010 Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data Pharmacol Rep 62 4 564 577 20884998 1:CAS:528:DC%2BC3MXitFGju7w%3D
191. A Wesolowska A Nikiforuk K Stachowicz E Tatarczynska 2006 Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression Neuropharmacology 51 3 578 586 16828124 1:CAS:528: DC%2BD28XotlOjt7Y%3D 10.1016/j.neuropharm.2006.04.017 S0028-3908(06)00123-7
192. K Wimalasena 2011 Vesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistry Med Res Rev 31 4 483 519 10.1002/med.20187 20135628 1:CAS:528:DC%2BC3MXnvFamt70%3D 10.1002/med.20187
193. JM Witkin M Baez J Yu ME Barton HE Shannon 2007 Constitutive deletion of the serotonin-7 (5-HT(7)) receptor decreases electrical and chemical seizure thresholds Epilepsy Res 75 1 39 45 17485199 1:CAS:528:DC%2BD2sXmtlamu74%3D 10.1016/j.eplepsyres.2007.03.017 S0920-1211(07)00105-2
194. AV Witte A Floel P Stein M Savli LK Mien W Wadsak C Spindelegger U Moser M Fink A Hahn M Mitterhauser K Kletter S Kasper R Lanzenberger 2009 Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects Hum Brain Mapp 30 8 2558 2570 10.1002/hbm.20687 19086022 10.1002/hbm.20687
195. Wooten D, Hillmer A, Murali D, Barnhart T, Schneider ML, Mukherjee J, Christian BT (2011a) An in vivo comparison of cis- and trans-[(18)F]mefway in the nonhuman primate. Nucl Med Biol. pii: S0969-8051(11)00111-9
196. DW Wooten JD Moraino AT Hillmer JW Engle OJ Dejesus D Murali TE Barnhart RJ Nickles RJ Davidson ML Schneider J Mukherjee BT Christian 2011 In vivo kinetics of [F-18]MEFWAY: a comparison with [C-11]WAY100635 and [F-18]MPPF in the nonhuman primate Synapse 65 7 592 600 10.1002/syn.20878 21484878 1:CAS:528:DC%2BC3MXksVKgtrg%3D 10.1002/syn.20878
197. R Xu J Hong CL Morse VW Pike 2010 Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography J Med Chem 53 19 7035 7047 10.1021/jm100668r 20812727 1:CAS:528:DC%2BC3cXhtFWlsLfK 10.1021/jm100668r
198. LN Yatham PF Liddle IS Shiah RW Lam MJ Adam AP Zis TJ Ruth 2001 Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET study Br J Psychiatry 178 448 453 11331561 1:STN:280:DC%2BD3Mzps1ertQ%3D%3D 10.1192/bjp.178.5.448
199. A Yosifova T Mushiroda D Stoianov R Vazharova I Dimova S Karachanak I Zaharieva V Milanova N Madjirova I Gerdjikov T Tolev S Velkova G Kirov MJ Owen MC O'Donovan D Toncheva Y Nakamura 2009 Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population J Affect Disord 117 1-2 87 97 19328558 1:CAS:528:DC%2BD1MXosVGgur4%3D 10.1016/j.jad.2008.12.021 S0165-0327(09)00003-2
200. MR Zhang T Haradahira J Maeda T Okauchi T Kida S Obayashi K Suzuki T Suhara 2002 Synthesis and preliminary PET study of the 5-HT7 receptor antagonist [C-11]DR4446 J Label Compd Rad 45 10 857 866 10.1002/jlcr.606 1:CAS:528:DC%2BD38Xns1equ78%3D 10.1002/jlcr.606
201. QJ Zhang LB Li XL Niu J Liu ZH Gui JJ Feng U Ali YP Hui ZH Wu 2011 The pyramidal neurons in the medial prefrontal cortex show decreased response to 5-hydroxytryptamine-3 receptor stimulation in a rodent model of Parkinson's disease Brain Res 1384 69 79 21291871 1:CAS:528:DC%2BC3MXjvV2msr8%3D 10.1016/j.brainres.2011.01.086 S0006-8993(11)00194-6
202. 18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2 Nucl Med Biol 37 2 133 141 20152712 1:CAS:528: DC%2BC3cXhs1ygt7Y%3D 10.1016/j.nucmedbio.2009.10.005 S0969-8051(09)00253-4
203. BC Zou L Dong Y Wang SH Wang MB Cao 2007 Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome Chin Med J (Engl) 120 23 2069 2074 1:CAS:528:DC%2BD1cXht12lu78%3D